Edit
Silk Road Medical
http://www.silkroadmedical.com/Last activity: 15.10.2025
Active - Reference to Silk Road Medical, Inc.
Silk Road Medial, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.
In April 2011, Warburg Pincus led a Series B financing of Silk Road. Subsequently, Warburg Pincus has continued to invest to support product development and clinical trials of the company’s technology. In April 2019, Silk Road Medical successfully executed its IPO on the NASDAQ.
In April 2011, Warburg Pincus led a Series B financing of Silk Road. Subsequently, Warburg Pincus has continued to invest to support product development and clinical trials of the company’s technology. In April 2019, Silk Road Medical successfully executed its IPO on the NASDAQ.
Total raised: $22.5M
Investors 2
| Date | Name | Website |
| - | CRG | crglp.com |
| - | Warburg Pi... | warburgpin... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.08.2014 | - | $22.5M | - |
Mentions in press and media 8
| Date | Title | Description |
| 15.10.2025 | Industry veterans join Lifesciences and fashion-tech startups | MetaLead Therapeutics, a spinoff of the University of Zurich, has developed a novel metal-binding peptide platform to create best-in-class therapeutics that target pathological metals, restore healthy balance, or deliver therapeutic counte... |
| 19.07.2017 | Silk Road raises $47M to grow stroke-prevention business | Silk Road Medical has raised $47 million to commercialize its stroke-prevention devices in the U.S. and overseas. The funding positions Silk Road to build on approvals and reimbursement nods it has picked up on both sides of the Atlantic fo... |
| 18.07.2017 | Silk Road Medical Raises $47M in Financing | Silk Road Medical, Inc., a Sunnyvale, CA-based company dedicated to treating stroke through surgical innovation, received $47m in funding. The round was led by new investors Norwest Venture Partners and funds managed by Janus Capital Manage... |
| 20.10.2015 | Silk Road Medical Announces up to $57 Million in New Funding for Novel Approach to Preventing Strokes | - |
| 20.10.2015 | Silk Road Medical Receives up to $57M in Equity and Debt Funding | Silk Road Medical, a Sunnyvale, CA-based developer of novel surgical technologies to prevent stroke, received up to $57m in equity and debt funding. CRG, a healthcare investment firm and a new investor in Silk Road Medical, led the debt fin... |
| 14.08.2014 | Stent-maker Silk Road Medical in the stroke prevention biz; raising $22.5 million | And Silk Road’s less-invasive device allows doctors to insert a stent directly from the neck, as opposed to the femoral artery in the groin – thus avoiding complications associated with working through extra piping in the body. “That leaves... |
| 19.04.2011 | Silk Road Medical Collects $8M | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Silk Road Medical, a stealth-mode developer of medical devices for neurovascular conditions in Sunnyvale, CA, has raised $8.2 million in equity-based financing in a round that... |
| - | Stent-maker Silk Road Medical in the stroke prevention biz; raising $22.5 million | About half of all strokes could be caused by a narrowing of the carotid artery – the pipeline that ushers blood flow through the neck and to the brain. The Bay Area’s Silk Road Medical may have found a less-invasive way to increase the bloo... |